The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-26
DOI
10.1111/head.14642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real world evidence of changes in CGRP monoclonal antibody and onabotulinumtoxinA prescription practices at the start of the COVID‐19 pandemic: An observational, retrospective study
- (2023) Leon S. Moskatel et al. HEADACHE
- Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
- (2022) Andreas A. Argyriou et al. ACTA NEUROLOGICA SCANDINAVICA
- Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study
- (2022) Patricia Pozo-Rosich et al. CURRENT MEDICAL RESEARCH AND OPINION
- A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
- (2022) Lynda J. Krasenbaum et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
- (2022) Marc Ehrlich et al. JOURNAL OF HEADACHE AND PAIN
- Costs and Utilization of New-to-Market Neurologic Medications
- (2022) Evan L Reynolds et al. NEUROLOGY
- Hypertension: A new safety risk for patients treated with erenumab
- (2021) Suprat Saely et al. HEADACHE
- CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis
- (2021) Florian Frank et al. CEPHALALGIA
- Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
- (2021) Lucas Hendrik Overeem et al. CNS DRUGS
- Safety and tolerability of preventive treatment options for chronic migraine
- (2021) Amanda Tinsley et al. Expert Opinion On Drug Safety
- Preventive Migraine Treatment
- (2021) Rebecca Burch CONTINUUM Lifelong Learning in Neurology
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- A prospective real-world analysis of erenumab in refractory chronic migraine
- (2020) Giorgio Lambru et al. JOURNAL OF HEADACHE AND PAIN
- An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
- (2019) Fayyaz Ahmed et al. JOURNAL OF HEADACHE AND PAIN
- A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
- (2018) Angelo Camporeale et al. BMC Neurology
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Validation of the Social support and Pain Questionnaire (SPQ) in patients with painful temporomandibular disorders
- (2017) Songlin He et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review of Migraine Prophylaxis Adherence and Persistence
- (2016) Zsolt Hepp et al. JOURNAL OF MANAGED CARE PHARMACY
- Trends in the Ambulatory Management of Headache: Analysis of NAMCS and NHAMCS Data 1999–2010
- (2015) John N. Mafi et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
- (2014) John F. Rothrock et al. HEADACHE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started